Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results - CNBC

The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia.

By: CNBC

Sep 15 2024
0
0 Views

Pfizer's experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said Satur… [+3647 chars]

The Fanatic Amateur Investors Behind Palantir - The Wall Street Journal

‘Serious energy deflation’ is coming whether Trump or Harris wins, says analyst - Yahoo Finance

Disney, DirecTV Reach Deal Ending Blackout of ESPN, ABC and More - Variety

Home Depot to pay $2 million settlement for overcharging customers - CNN

25 New Buys After Year's Best Week; Now Powell Is Up - Investor's Business Daily

Trump lashes out at Nasdaq over routine trading halt of Truth Social - CNN

Share this page

Guest Posts by Easy Branches

Banner advertising on easybranches network

all our websites